Biosimilars Research in Solid Tumors

Funding Agency:
Pfizer Inc.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the research gaps as outlined in the specific RFP.


General Area of Interest for this RFP: Proposals for interventional, non-interventional, basic science, or other studies that include but not limited to:

• Demonstrate the value or economic benefit of the biosimilar

• Incorporate Real World Data and/or Patient Reported Outcomes

• Evaluate the integration of the biosimilar with a standard-of-care regimen in an approved indication not previously evaluated

• Explore rational treatment combinations with other Pfizer medicines

• Grant Application due date: October 15, 2019

Agency Website

Eligibility Requirements

Geographic Scope: Countries where Pfizer’s trastuzumab and bevacizumab biosimilars have received regulatory approval

• The institution and principal investigator (PI) must be based in one of the eligible countries noted above. • Only organizations are eligible to receive grants, not individuals or medical practice groups. • The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. • Applicant must be affiliated with a host institution

Amount Description

The estimated total available budget related to this RFP in 2019 is $500,000. Additional funding available for study payments in 2020 and 2021. Grant monetary size may vary and there is no stated maximum.  Approximately 4-6 are studies are expected to be supported.

Funding Type





Medical - Basic Science

External Deadline

October 15, 2019